Exelixis, Inc.

Equities

EXEL

US30161Q1040

Market Closed - Nasdaq Other stock markets 20:00:00 11/03/2026 GMT			5-day change	1st Jan Change
41.75 ^USD	+1.11%		+0.14%	-4.75%

03-11	Exelixis, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 12:00 PM
03-11	Exelixis, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 09:35 AM

Transcript : Exelixis, Inc., Q3 2025 Earnings Call, Nov 04, 2025

Published on 11/05/2025 at 12:35 am GMT - Modified on 11/05/2025 at 02:07 am GMT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, ladies and gentlemen, and welcome to the Exelixis' Third Quarter 2025 Financial Results Conference Call. My name is Sherry, and I'll be your

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Exelixis, Inc.

03-11	Exelixis, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 12:00 PM
03-11	Exelixis, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 09:35 AM
03-10	Exelixis, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 10:40 AM
03-03	Exelixis, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 01:10 PM
03-02	RBC Lowers Price Target on Exelixis to $43 From $46, Keeps Sector Perform Rating	MT
02-23	Exelixis Insider Sold Shares Worth $4,382,252, According to a Recent SEC Filing	MT
02-20	Exelixis Insider Sold Shares Worth $4,687,346, According to a Recent SEC Filing	MT
02-19	Exelixis Insider Sold Shares Worth $821,623, According to a Recent SEC Filing	MT
02-19	Exelixis Insider Sold Shares Worth $1,325,339, According to a Recent SEC Filing	MT
02-19	Exelixis Insider Sold Shares Worth $2,950,941, According to a Recent SEC Filing	MT
02-19	Exelixis Insider Sold Shares Worth $2,810,998, According to a Recent SEC Filing	MT
02-11	Biogen Inc. Announces Board Changes	CI
02-11	RBC Raises Price Target on Exelixis to $46 From $45, Keeps Sector Perform Rating	MT
02-11	Exelixis, Inc., Q4 2025 Earnings Call, Feb 10, 2026
02-10	(EXEL) Exelixis Expects Full Year 2026 Revenue Range $2.53B - $2.63B, vs. FactSet Est of $2.62B	MT